Your browser doesn't support javascript.
loading
The Prognostic Significance of CD79B Mutation in Diffuse Large B-Cell Lymphoma: A Meta-analysis and Systematic Literature Review.
Xu, Peng-Peng; Shen, Rong; Shi, Zi-Yang; Cheng, Shu; Wang, Li; Liu, Yang; Zhang, Lu; Huang, Ruiqi; Ma, Xiaopeng; Wu, Xikun; Yao, Hui; Yu, Yiling; Zhao, Wei-Li.
Afiliação
  • Xu PP; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shen R; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shi ZY; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Cheng S; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wang L; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Pôle de Recherches Sino-Français en Science du Vivant et Génom
  • Liu Y; BeiGene (Shanghai) Co. Ltd., Shanghai, China.
  • Zhang L; BeiGene (Shanghai) Co. Ltd., Shanghai, China.
  • Huang R; BeiGene (Shanghai) Co. Ltd., Shanghai, China.
  • Ma X; BeiGene (Shanghai) Co. Ltd., Shanghai, China.
  • Wu X; BeiGene (Shanghai) Co. Ltd., Shanghai, China.
  • Yao H; BeiGene (Shanghai) Co. Ltd., Shanghai, China.
  • Yu Y; BeiGene (Shanghai) Co. Ltd., Shanghai, China.
  • Zhao WL; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Pôle de Recherches Sino-Français en Science du Vivant et Génom
Clin Lymphoma Myeloma Leuk ; 22(12): e1051-e1058.e1, 2022 12.
Article em En | MEDLINE | ID: mdl-36182550
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Fator 88 de Diferenciação Mieloide Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Clin Lymphoma Myeloma Leuk Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Fator 88 de Diferenciação Mieloide Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Clin Lymphoma Myeloma Leuk Ano de publicação: 2022 Tipo de documento: Article